Alzheimer disease and cancer
- 8 March 2005
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (5) , 895-898
- https://doi.org/10.1212/01.wnl.0000152889.94785.51
Abstract
Cross-sectional studies raise the possibility of protective relationships between, or a common mechanism underlying, the development of dementia of the Alzheimer type (DAT) and cancer. Using a prospective longitudinal design, the authors found that the risk of developing cancer is less among participants with DAT vs nondemented participants (p < 0.001) and that the risk of developing DAT may be less for participants with a history of cancer (p = 0.060).Keywords
This publication has 9 references indexed in Scilit:
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Biochemical Markers of Individual Response to Growth Hormone Replacement in AdultsHormone Research in Paediatrics, 2001
- Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern ManhattanNeurology, 2001
- Prevalence and Risks of Dementia in the Japanese Population: RERF's Adult Health Study Hiroshima SubjectsJournal of the American Geriatrics Society, 1999
- Validity of self-reported Cancers in a Propsective Cohort Study in Comparison with Data from State Cancer RegistriesAmerican Journal of Epidemiology, 1998
- Clinicopathologic Studies in Cognitively Healthy Aging and Alzheimer DiseaseArchives of Neurology, 1998
- The Clinical Dementia Rating (CDR)Neurology, 1993
- Coexistence of Alzheimer's Disease and Diabetes MellitusJournal of the American Geriatrics Society, 1992
- Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population.Journal of Neurology, Neurosurgery & Psychiatry, 1982